Related Experiment Video

Updated: Aug 30, 2026

Development of a Murine Model for Femoral Artery Anastomotic Stenosis
05:42

Development of a Murine Model for Femoral Artery Anastomotic Stenosis

Published on: April 18, 2025

MCP-1 deficiency is associated with reduced intimal hyperplasia after arterial injury

William J H Kim1, Igor Chereshnev, Mihaela Gazdoiu

  • 1The Zena and Michael A Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY, USA.

Biochemical and Biophysical Research Communications
|October 11, 2003
PubMed

Insights

Monocyte chemoattractant protein-1 (MCP-1) deficiency reduced intimal hyperplasia after arterial injury, suggesting its role in smooth muscle cell migration. This contrasts with CCR2 deficiency, highlighting distinct roles in vascular injury.

Area of Science:

  • Vascular Biology
  • Immunology
  • Cardiovascular Research

Background:

  • Monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 are key in macrophage accumulation within atherosclerotic plaques and injured arteries.
  • Previous studies showed CCR2 deficiency significantly reduces intimal hyperplasia and medial DNA synthesis post-arterial injury.

Purpose of the Study:

  • To investigate the specific role of MCP-1 in the arterial injury response.
  • To compare the effects of MCP-1 deficiency with previously observed CCR2 deficiency in a mouse model of femoral arterial injury.

Main Methods:

  • Analysis of intimal hyperplasia and medial DNA synthesis in MCP-1 knockout (MCP-1(-/-)) mice following femoral arterial injury.
  • Assessment of neointimal tissue factor expression after injury.

Main Results:

  • MCP-1 deficiency resulted in a ~30% reduction in intimal hyperplasia at 4 weeks post-injury.
  • MCP-1 deficiency did not significantly affect medial DNA synthesis.
  • Neointimal tissue factor levels were not decreased in MCP-1 deficient mice.

Conclusions:

  • MCP-1 deficiency has distinct effects on arterial injury compared to CCR2 deficiency.
  • MCP-1's contribution to intimal hyperplasia appears to be primarily mediated through smooth muscle cell migration.

More Related Videos

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application06:53

A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application

Published on: July 9, 2020

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function06:14

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

Published on: June 11, 2017

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...